121 related articles for article (PubMed ID: 11400568)
1. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
Bracher F; Krauss J; Laufer S
Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
[No Abstract] [Full Text] [Related]
2. Possible inconsistencies in study on cyclooxygenase.
Kay-Mugford T; Conlon P
Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
[No Abstract] [Full Text] [Related]
3. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
4. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
Steinhilber D
Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
[No Abstract] [Full Text] [Related]
5. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
Buccellati C; Sala A; Ballerio R; Bianchib M
Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
[TBL] [Abstract][Full Text] [Related]
6. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
8. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
Vanegas H
Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
[No Abstract] [Full Text] [Related]
9. COX in a crystal ball: current status and future promise of prostaglandin research.
FitzGerald GA; Loll P
J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
[No Abstract] [Full Text] [Related]
10. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
11. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
12. 5-Methylflavasperone and rhamnetin from Guiera senegalensis and their antioxidative and 5-lipoxygenase inhibitory activity.
Bucar F; Resch M; Bauer R; Burits M; Knauder E; Schubert-Zsilavecz M
Pharmazie; 1998 Dec; 53(12):875-8. PubMed ID: 9879572
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
Richwien A; Wurm G
Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygenase-1 and 5-lipoxygenase inhibitors.
Laufer S; Striegel HG; Neher K; Zechmeister P; Donat C; Stolingwa K; Baur S; Tries S; Kammermeier T; Dannhardt G; Kiefer W
Arch Pharm (Weinheim); 1997 Oct; 330(9-10):307-12. PubMed ID: 9396390
[TBL] [Abstract][Full Text] [Related]
15. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors.
Park CH; Siomboing X; Yous S; Gressier B; Luyckx M; Chavatte P
Eur J Med Chem; 2002 Jun; 37(6):461-8. PubMed ID: 12204472
[TBL] [Abstract][Full Text] [Related]
16. The development of COX2 inhibitors.
Flower RJ
Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
[TBL] [Abstract][Full Text] [Related]
17. [A heterogenous drug class. NSAID: classification and spectrum of action].
Ulbrich H; Dannhardt G
Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
[No Abstract] [Full Text] [Related]
18. Inhibitory effect of phospholipid hydroperoxide glutathione peroxidase on the activity of lipoxygenases and cyclooxygenases.
Huang HS; Chen CJ; Suzuki H; Yamamoto S; Chang WC
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):65-75. PubMed ID: 10560610
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
